Manitoba Crop Alliance Issuing Cash Advances On Winter Cereals Planted This Fall

Oct 13, 2021

The Manitoba Crop Alliance (MCA) has received approval to start issuing cash advances on winter wheat and fall rye planted fall 2021 through Agriculture and Agri-Food Canada’s Advance Payments Program (APP).

Under the program, eligible farmers are eligible for up to $1,000,000 with the Government of Canada paying the interest on the first $100,000 of the advance. Funds can be issued in three to five business days once the application process is complete. MCA’s interest rate on interest-bearing cash advances is a competitive rate with major banks and credit unions.

“Manitoba Crop Alliance provides quick, courteous service when farmers apply for and manage their APP cash advance,” said MCA chair, Fred Greig. “When a farmer phones or emails the MCA office, they will be speaking with staff who know the program and can provide answers to any questions farmers have.”

Manitoba Crop Alliance also continues to process applications for the 2021 program year on over 35 crop kinds and honey.

Click here to see more...

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.